3SCHNEIDER M. Characteristics of SonoVue trade mark[J]. Echocardiography,1999, 16 (7Pt2): 743-746.
4MOREL D R,SCHWIEGER I,HOHN L,et al. Human pharmcokinetics and safety evaluation of SonoVue, a new contrast agent for ultrasound imaging[J]. Invest Radiol,2000,35(1): 80-85.
5BOKOR D,CHAMBERS J B,REES P J,et al.Clinical safety of SonoVue, a new contrast agent for ultrasound imaging, in healthy volunteers and in patients with chronic obstructive pulmonary disease[J]. Invest Radiol,2001,36(2):104-109.
6NANDA N C,WISTRAN D C,KARLSBERG R P,et al. Multicenter evaluation of SonoVue for improved endocardial border delineation[J]. Echocardiography,2002,19(1):27-36.
7BOKOR D. Diagnostic efficacy of SonoVue[J]. J Am Coll Cardiol, 2000,86(4A):19G-24G.
8MASUGATA H,LAFITTE S,PETERS B,et al. Comparison of real-time and intermittent triggered myocardial contrast echocardiography for quantification of coronary stenosis severity and transmural perfusion gradient[J]. Circulation, 2001,104(13):1550-1556.
9JANARDHANAN R,SENIOR R. Accuracy of dipyridamole myocardial contrast echo- cardiography for the detection of residual stenosis of the infarct-related artery and multivessel disease early after acute myocardial infarction[J]. J Am Coll Cardiol,2004,43(12):2247-2252.
10LAFITTE S,HIGASHIYAMA A,MASUGATA H,et al. Contrast echocardiography can assess risk area and infarct size during coronary occlusion and reperfusion: experimental validation[J]. J Am Coll Cardiol,2002,39(9):1546-1554.
二级参考文献11
1[1]Grayburn PA,Mulvagh S,Crouse L.Left ventricular opacification at rest and during stress.Am J Cardiol.2002,90(Suppl 10A):21J-27J
2[2]Becher H.Contrast echocardiography:clinical applications and fu-ture prospects.Herz.2002,27(3):201-216
3[3]Al-Mansour HA,Mulvagh SL,Pumper GM,Klarich KW,Foley DA.Usefulness of harmonic imaging for left ventricular opacification and endocardial border delineation by optison.Am J Cardiol.2000,85(6):795-799
4[4]Nanda NC,Wistran DC,Karlsberg RP,Hack TC,Smith WB,Foley DA,Picard MH,Cotter B.Multicenter evaluation of SonoVue for improved endocardial border delineation.Echocardiography.2002,19(1):27-36
5[5]Dolan MS,El-Shafei A,Puri S,Tamirisa K,St Vrain J,Flanagan J,Havens E,Labovitz AJ.For left ventricular opacification and endocardial border definition:is it really important which contrast agent we use,or is it the imaging modality we choose? Eur J Echocardiogr.2001,2(3):154-162
6[6]Dolan MS,Riad K,El-Shafei A,Puri S,Tamirisa K,Bierig M,St Vrain J,McKinney L,Havens E,Habermehl K,Pyatt L,Kern M,Labovitz AJ.Effect of intravenous contrast for left ventricular opacification and border definition on sensitivity and specificity of dobutamine stress echocardiography compared with coronary angiography in technically difficult patients.Am Heart J.2001,142(5):908-915
7[7]Chen L,Colonna P,Corda M,Cadeddu C,Montisci R,Caiati C,Meloni L,Iliceto S.Contrast-enhanced harmonic color Doppler for left ventricular opacification:improved endocardial border definition compared to tissue harmonic imaging and optimization of methodology in patients with suboptimal echocardiograms.Echocardiography.2001,18(8):639-649
8[8]Shimoni S,Frangogiannis NG,Aggeli CJ,Shan K,Quinones MA,Espada R,Letsou GV,Lawrie GM,Winters WL,Reardon MJ,Zoghbi WA.Microvascular structural correlates of myocardial contrast echocardiography in patients with coronary artery disease and left ventricular dysfunction:implications for the assessment of myocardial hibernation.Circulation 2002,106 (8):950-956
10Chen L D,Xu H X,Xie X Y,et al.Enhancement Patterns ofin Tra Hepatic Cholan Giocarcinoma:Comparison betweenContrast-enhanced Ultrasound and Contrast-enhanced CT[J].Br J Radiol,2008,81(971):881-889.
